HSPA9 and lip and oral cavity carcinoma: To investigate the molecular mechanism and therapeutic efficacy of mortalin targeting in oral cancer, we examined its expression in HSC3 and SAS oral cancer cells compared to normal keratinocytes, HaCaT (Figure S1, Document S1).